Skip to ContentSkip to Navigation
How to find us dr. A.M.E. (Annemiek) Walenkamp

Publications

Comparison of F-18-DOPA Versus Ga-68-DOTATOC as Preferred PET Imaging Tracer in Well-Differentiated Neuroendocrine Neoplasms

Comparison of 18F-DOPA versus 68Ga-DOTA-TOC as preferred PET imaging tracer in well-differentiated neuroendocrine neoplasms

Current Treatment Strategies and Future Directions for Extrapulmonary Neuroendocrine Carcinomas A Review: A Review

Impact of depatuxizumab mafodotin on health-related quality of life and neurological functioning in the phase II EORTC 1410/INTELLANCE 2 trial for EGFR-amplified recurrent glioblastoma

At the bedside: Profiling and treating patients with CXCR4-expressing cancers

Corrigendum to "Dopamine and serotonin regulate tumor behavior by affecting angiogenesis" [Drug Resist. Updat. 17 (2014) 96-104]

Data-driven prioritization and preclinical evaluation of therapeutic targets in glioblastoma

Effect of a tailored exercise intervention during or after chemotherapy on cardiovascular morbidity in cancer patients.

EGFR mutations are associated with response to depatux-m in combination with temozolomide and result in a receptor that is hypersensitive to ligand

High hepatocyte growth factor expression in primary tumor predicts better overall survival in male breast cancer

Read more